About this Research Topic
A Heart Team is founded on a multidisciplinary approach to patient selection and treatment. The term Heart Team has been stressed whenever delicate decisions were pending regarding a patients’ medical care. In the innovative field of transcatheter valve therapies, an effective Heart Team is beneficial from both an economic viewpoint and for the individual patient. The ideal Heart Team takes sole responsibility for unbiased discussion and decision and moreover for high quality therapies.
The goal of this research topic is to leverage the particular expertise of Interventional Cardiologists and Cardiac Surgeons and to bring together the best of both specialities. Burning issues of transcatheter valve therapy are elucidated from the cardiological, conservative and surgical views to broaden the perspective on the therapeutic options.
Latest data on aortic stenosis indicate at least non-inferiority for Transcatheter Aortic Valve Implantation (TAVI) also in low-risk patients. It is important to accurately define the patient population who benefits from TAVI or SAVR (Surgical Aortic Valve Replacement) including individual anatomy and comorbidities. In the mitral and tricuspid valve field, there continues to be a lack of data to precisely determine the patient population who benefits from an intervention over surgery. The importance of imaging is highlighted by characterization of the rapid advancements in this field. Finally, there will be a focus on the difficulty of complex problems beyond the scope of controlled studies or guidelines, such as redo situations or multivalvular disease. All topics within the issue will be addressed through an interdisciplinary perspective.
We invite authors to submit original research articles or review articles regarding TAVI in low risk and younger patients, coronary artery disease and aortic stenosis, challenging anatomies for TAVI (such as bicuspid), prosthesis-patient mismatch, and patient-tailored aortic valve replacement. In the mitral and tricuspid field, we invite publications on indications for surgical vs. percutaneous mitral intervention, multimodality imaging for transcatheter mitral interventions, and evaluation and treatment of tricuspid insufficiency. We also invite submissions on the topics of management of patients with multiple valvular disease and redo aortic or mitral surgery vs. transcatheter valve-in-valve therapy.
One of the Topic Editors Martin Swaans is a Proctor/consultant for Abbott Vascular, Boston Scientific, Philips Healthcare and Bioventrix inc.
Another of the Topic Editors Sabine Bleiziffer is a Proctor/consultant for Medtronic and Boston Scientific.
Keywords: aortic stenosis, mitral regurgitation, tricuspid regurgitation, transcatheter valve intervention, heart team
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.